<DOC>
	<DOCNO>NCT01744964</DOCNO>
	<brief_summary>The aim study assess effect dopamine agonist apomorphine experimental pain model healthy subject explore possible association effect common polymorphism within dopamine transporter gene .</brief_summary>
	<brief_title>Apomorphine Effects Experimental Pain</brief_title>
	<detailed_description>Healthy volunteer ( n=105 ) participate randomized double-blind , placebo-controlled , cross-over trial . Heat pain threshold intensity , cold pain threshold , response tonic cold pain ( latency , intensity , tolerance ) evaluate 120 min administration 1.5 mg apomorphine/placebo . A polymorphism ( DAT-1 ) within dopamine transporter gene ( SLC6A3 ) investigate .</detailed_description>
	<mesh_term>Dopamine</mesh_term>
	<mesh_term>Dopamine Agents</mesh_term>
	<mesh_term>Apomorphine</mesh_term>
	<criteria>healthy free chronic pain type use medication oral contraceptive able understand purpose instruction study . type medical painful condition use medication recreational drug pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>apomorphine</keyword>
	<keyword>dopamine transporter gene</keyword>
	<keyword>SLC6A3</keyword>
	<keyword>cold pressor test</keyword>
	<keyword>tolerance</keyword>
	<keyword>experimental pain</keyword>
	<keyword>dopamine agonist</keyword>
</DOC>